August 20, 2011
Life value
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
From August 15 – 19, 2011, the delegates from WHO International have inspected STADA plant at VSIP.
The inspection has been done successfully and we are expected to get the certificate in the near future. It is really a pride for STADA-VN in particular and for Vietnam pharmaceutical field in general.
This success is a result of great efforts of all employees of STADA-VN during the last time.
STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com
Continuing the program of the 32nd session, on the afternoon of April 16, the National Assembly Standing Committee gave opinions on the Law Project amending and supplementing a number of articles of the Pharmacy Law. Reporting at the meeting, Minister of Health Dao Hong Lan said that compared to the current law, the draft Law
The version grants pharmaceutical business licenses to non-profit pharmaceutical entities that engage in commercial activities to ensure essential medicines reach a wider range of the population. HÀ NỘI — A revised version of the Law on Pharmaceuticals 2016 will be presented to the National Assembly for discussion and feedback during a legislative meeting from June